Abbott Acquires Bigfoot Biomedical. Unity has a new home. Some Bigfoot employees might not like it.

In mid-September 2023, the medical technology startup known as Bigfoot Biomedical, reached a definitive agreement to be acquired by Abbott Laboratories (see the official press release athttps://www.prnewswire.com/news-releases/abbott-to-acquire-bigfoot-biomedical-furthering-efforts-to-develop-personalized-connected-solutions-for-people-with-diabetes-301918254.html for details). Financial terms of the deal were not disclosed. Bigfoot ' s CEO Was Fired from JDRFSome people with diabetes might recall that Bigfoot Biomedical was co-founded by Jeffrey Brewer, whose previous job was as CEO of the JDRF. But Mr. Brewer was shown the door at JDRF. Jeff Brewer left JDRF in July 2014, and he became CEO of Bigfoot Biomedical in November 2014, which was roughly 4 months later. His unannounced departure from JDRF occurred rather suddenly, and yet full details on his departure were never made public. Bigfoot Biomedical began in November 2014 on the other side of the country (JDRF is based in New York, while Bigfoot was based in the San Francisco Bay Area in the Santa Clara County town of Milpitas, which is adjacent to San Jose. My only recollections of Milpitas was when theGreat Mall opened back in 1994, as I was living in the Bay Area at the time). Such timing would be impossible unless Mr. Brewer was working on itwhile he was still employed at the JDRF. I must presume Jeff Brewer was conducting business for his startup while still on JDRF ' s payroll, and the JDRF Board discovered th...
Source: Scott's Web Log - Category: Endocrinology Tags: 2023 Abbott Bigfoot Biomedical Bigfoot Unity Dexcom FTC Source Type: blogs